Author

George Firth

St Thomas' HospitalORCID 0000-0003-1603-5067Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:human· 1 Assay:imaging· 1 Organism:mouse· 1 Organism:zebrafish· 1

Frequent Co-Authors

Abigail R. BarberiD· 1 shared Ahad A. RahimiD· 1 shared Aimee FalzoneiD· 1 shared Amy F. GeardiD· 1 shared Andrew McGowniD· 1 shared Ariana HuebneriD· 1 shared Charles SwantoniD· 1 shared Chiara Pojani· 1 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Abigail R. BarberORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Pharmacology & ToxicologyBiochemical PharmacologyPeer-reviewedSep 11, 2026

A novel pipeline for the validation of manganese chelators for the treatment of manganese overload

Hendrik Vogt, Chiara Pojani, Jack Devonport…·Karin Tuschl

This paper develops a pipeline to identify and evaluate novel manganese chelators using zebrafish and mouse models, finding that H3PyC3A and Me3PyC3A show improved manganese mobilization and reduced accumulation.

1 citation

zebrafishmouse

𝕏 PostBluesky

Cancer BiologyNature CommunicationsPeer-reviewedDec 17, 2024

Imaging the master regulator of the antioxidant response in non-small cell lung cancer with positron emission tomography

Hannah E. Greenwood, Abigail R. Barber, Richard S. Edwards…·Timothy Howard Witney

This study uses PET imaging to assess NRF2 activation in NSCLC, showing [18F]FSPG as a marker of therapeutic resistance and a potential target for treatment.

36 citationstop 4%

humanimaging

𝕏 PostBluesky